Literature DB >> 4063541

The total compliance of the respiratory system during the first year of life.

A H Thomson, C S Beardsmore, M Silverman.   

Abstract

Respiratory system compliance (Crs) was measured in 34 spontaneously breathing infants during the first year of life. An occlusion technique was used whereby several expiratory occlusions were performed at different lung volumes within the tidal range. The airway opening pressure generated during a plateau after occlusion was related to the volume included above the end-tidal level by a regression equation. The slope of this equation represented the compliance of the infant's respiratory system; the intercept was significantly different for preterm (-0.5 ml) and post-term (-5.5 ml) infants and may represent the difference between end-expiratory lung volume during tidal breathing and the relaxed functional residual capacity. The values for respiratory system compliance were similar to those previously reported for infants during muscle relaxation. As a function of body length, Crs = 1.58 X length3.13 X 10(-4) ml . kPa-1. The technique described is simple to apply and is independent of oesophageal pressure measurements.

Entities:  

Mesh:

Year:  1985        PMID: 4063541

Source DB:  PubMed          Journal:  Bull Eur Physiopathol Respir        ISSN: 0395-3890


  3 in total

1.  Static respiratory compliance in the newborn. I: A clinical and prognostic index for mechanically ventilated infants.

Authors:  W O Tarnow-Mordi; R A Wilkie; E Reid
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

2.  Pressure-volume curves, static compliances and gas exchange in hyaline membrane disease during conventional mechanical and high-frequency ventilation.

Authors:  J Pfenninger; C Minder
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  Reliability of clinical assessments of respiratory system compliance (Crs) made by junior doctors.

Authors:  B J Stenson; R A Wilkie; I A Laing; W O Tarnow-Mordi
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.